ScholarLens Back to search
2018•Warwick Research Archive Portal (University of Warwick)Requires access

Beta interferons and glatiramer acetate for treating multiple sclerosis

Xavier Armoiry, Peter Auguste, Aileen Clarke

Open publisher page 3 citations

Abstract

Evidence-based recommendations on beta interferons (Avonex, Betaferon, Extavia, Rebif) and glatiramer acetate (Copaxone) for treating multiple sclerosis in adults. \n \nThis guidance replaces NICE technology appraisal guidance 32 on beta interferon and glatiramer acetate for the treatment of multiple sclerosis.

Open-access reader

About this research paper

What this paper is about

Evidence-based recommendations on beta interferons (Avonex, Betaferon, Extavia, Rebif) and glatiramer acetate (Copaxone) for treating multiple sclerosis in adults. \n \nThis guidance replaces NICE technology appraisal guidance 32 on beta interferon and glatiramer acetate for the treatment of multiple sclerosis.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Evidence-based recommendations on beta interferons (Avonex, Betaferon, Extavia, Rebif) and glatiramer acetate (Copaxone) for treating multiple sclerosis in adults. \n \nThis guidance replaces NICE technology appraisal guidance 32 on beta interferon and glatiramer acetate for the treatment of multiple sclerosis.

Key concepts: Glatiramer acetate, Multiple sclerosis, Interferon beta, Medicine, Interferon beta-1b, Interferon beta-1a, Relapsing remitting, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Beta interferons and glatiramer acetate for treating multiple sclerosis — Research Paper | ScholarLens